MedTech News
.................... by Andrew Celentano
Tumors May Not Develop Randomly Across the Brain — Fruit Flies May Help Explain the Pattern
Brain tumor growth may depend not only on cancer-causing mutations, but also on the molecular conditions in specific brain regions.
AbbVie snags FDA’s first ADC approval for ultra-rare blood cancer
Decnupaz is the first antibody-drug conjugate for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancer.
Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment
Procept BioRobotics (Nasdaq:PRCT) announced today that it received FDA investigational device exemption (IDE) for a second Aquablation evaluation.
Breast tumors use sugar coating to evade immunity, opening potential immunotherapy path
An international research team led by the Medical University of Vienna has now identified a previously underestimated mechanism by which breast tumors evade the immune system.
Smartwatch seizure app spots 98% of tonic-clonic seizures, cuts false alarms
In people with epilepsy, a new study has found a smartwatch application accurately detected tonic-clonic seizures, seizures with major convulsions, with a low rate of false alarms. The study was published in Neurology Open Access.
Simple blood test could lead to personalized lung cancer treatment
A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, researchers have found. University of Queensland-led research focused on non-small cell lung cancer (NSCLC), the most common form of the disease, and showed how analyzing proteins in a blood sample could support earlier and better-informed treatment decisions.
New urine test may spot autism risk in children ages two to 11, study finds
The research, published in Molecular Psychiatry, points to a consistent biological pattern in many children with autism—elevated levels of specific metabolites in the gut.
Novel blood test detects rejection after lung transplant
A simple blood test could one day replace invasive biopsies for detecting acute cellular rejection (ACR) after lung transplantation, an American Journal of Transplantation study finds.